K2M Group Holdings, Inc. (NASDAQ:KTWO)‘s stock had its “buy” rating reissued by investment analysts at Piper Jaffray Companies in a note issued to investors on Friday. They presently have a $28.00 price target on the medical device company’s stock. Piper Jaffray Companies’ price target suggests a potential upside of 47.91% from the company’s previous close.

A number of other equities research analysts have also recently commented on KTWO. Cowen and Company set a $28.00 target price on K2M Group Holdings and gave the company a “buy” rating in a research report on Thursday, August 17th. William Blair reiterated an “outperform” rating on shares of K2M Group Holdings in a report on Tuesday, October 10th. Needham & Company LLC lowered their price objective on K2M Group Holdings from $27.00 to $26.00 and set a “strong-buy” rating on the stock in a report on Thursday. Oppenheimer Holdings, Inc. set a $29.00 price objective on K2M Group Holdings and gave the stock a “buy” rating in a report on Wednesday, August 2nd. Finally, BidaskClub cut K2M Group Holdings from a “buy” rating to a “hold” rating in a report on Monday, July 31st. One research analyst has rated the stock with a sell rating, one has given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $25.00.

Shares of K2M Group Holdings (NASDAQ KTWO) traded down $0.16 on Friday, reaching $18.93. The company’s stock had a trading volume of 357,739 shares, compared to its average volume of 773,942. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.91 and a current ratio of 3.06.

K2M Group Holdings (NASDAQ:KTWO) last posted its earnings results on Wednesday, November 1st. The medical device company reported ($0.20) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.19) by ($0.01). K2M Group Holdings had a negative net margin of 16.22% and a negative return on equity of 16.02%. The business had revenue of $62.65 million for the quarter, compared to analyst estimates of $62.69 million. During the same quarter last year, the business earned ($0.19) earnings per share. K2M Group Holdings’s revenue was up 5.6% on a year-over-year basis. equities analysts anticipate that K2M Group Holdings will post -0.83 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This story was reported by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/11/03/k2m-group-holdings-inc-ktwo-given-buy-rating-at-piper-jaffray-companies.html.

In other K2M Group Holdings news, CFO Gregory S. Cole sold 39,357 shares of the business’s stock in a transaction that occurred on Friday, August 11th. The stock was sold at an average price of $23.37, for a total value of $919,773.09. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider John Philip Md Kostuik sold 1,090 shares of the business’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $24.08, for a total value of $26,247.20. Following the completion of the sale, the insider now directly owns 201,961 shares in the company, valued at approximately $4,863,220.88. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 44,129 shares of company stock worth $1,033,644. Corporate insiders own 5.80% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in KTWO. Rockefeller Financial Services Inc. purchased a new stake in K2M Group Holdings in the third quarter valued at approximately $105,000. BNP Paribas Arbitrage SA grew its stake in shares of K2M Group Holdings by 5,175.3% in the second quarter. BNP Paribas Arbitrage SA now owns 4,484 shares of the medical device company’s stock worth $109,000 after acquiring an additional 4,399 shares in the last quarter. Legal & General Group Plc grew its stake in shares of K2M Group Holdings by 9.1% in the first quarter. Legal & General Group Plc now owns 6,763 shares of the medical device company’s stock worth $138,000 after acquiring an additional 564 shares in the last quarter. Dorsey & Whitney Trust CO LLC acquired a new position in shares of K2M Group Holdings in the second quarter worth $211,000. Finally, American International Group Inc. grew its stake in shares of K2M Group Holdings by 7.1% in the first quarter. American International Group Inc. now owns 15,847 shares of the medical device company’s stock worth $325,000 after acquiring an additional 1,047 shares in the last quarter. 99.13% of the stock is currently owned by institutional investors.

K2M Group Holdings Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.